Skip to content

Study · Non-randomized trial · 2013

1 result

Zinc-α2-glycoprotein is associated with insulin resistance in humans and is regulated by hyperglycemia, hyperinsulinemia, or liraglutide administration: cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes.

Yang M, Liu R, Li S, Luo Y, Zhang Y, Zhang L, Liu D, Wang Y, Xiong Z, Boden G, Chen S, Li L, Yang G

Diabetes care28 Dec 2012Cited by 92 (Europe PMC)

PMID23275352 (opens in a new tab)PMCIDPMC3631846 (opens in a new tab)DOI10.2337/dc12-0940 (opens in a new tab)PepBankPUB-23275352
Read at sourcePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialMechanism

    In people given liraglutide for 12 weeks, circulating ZAG levels rose significantly.

    In plain wordsIn people given liraglutide for 12 weeks, blood levels of the protein ZAG rose.

    Peptide
    Liraglutide
    Outcome
    IncreaseCirculating zinc-alpha2-glycoprotein (ZAG) after liraglutide
    Study

    n: not reported in source

    Outcome group
    Inflammation markers · Metabolic and weight
    Studied dose
    Dose not stated · 12 weeksAs given in this study (human).

    Source sentences

    Summary
    Liraglutide treatment for 12 weeks significantly increased circulating ZAG levels.
    1 context sentence
    Summary · context
    The effect of a glucagon-like peptide-1 agonist on ZAG was studied in a 12-week liraglutide treatment trial.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 12:10 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:05 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.